Literature DB >> 28956545

Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature.

Sheila Chiesi1, Daniela Piacentini1, Nicola Duccio Salerno1, Dora Luise1, Marta Peracchi2, Ercole Concia1, Angelo Cazzadori1, Enrico Piovan3, Massimiliano Lanzafame1.   

Abstract

We report the first Italian case of Mycobacterium chimaera disseminated infection in a patient with a history of cardiac surgery. The patient was initially diagnosed with sarcoidosis and started on immunosuppressive therapy. Ten months later she developed a vertebral osteomyelitis: M. chimaera was isolated from bone specimen. A review of the literature shows that M. chimaera infection occurs specifically in this population of patients, due to contamination of heater-cooler units used during cardiosurgery. Devices responsible for the transmission were produced by Sorin Group Deutschland. Mycobacterium chimaera infection should be included in the differential diagnosis for patients undergoing cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28956545

Source DB:  PubMed          Journal:  Infez Med        ISSN: 1124-9390


  3 in total

Review 1.  Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria.

Authors:  Elizabeth Ann Misch; Christopher Saddler; James Muse Davis
Journal:  Curr Infect Dis Rep       Date:  2018-03-19       Impact factor: 3.725

2.  Case report of the first cured patient with Mycobacterium Chimaera infection following cardiac valve replacement in the mainland of China.

Authors:  Di Lu; Chun-Hong Zhang; Li-Jiang Chen; Pei-Feng Jin; Xia-Fei Feng; Xi Zhou; Wei-Cong Huang; Jue Wang; Ying Dai; Yun Fu
Journal:  Antimicrob Resist Infect Control       Date:  2021-10-07       Impact factor: 4.887

Review 3.  Mycobacterium chimaera: a report of 2 new cases and literature review.

Authors:  Alice Natanti; Marco Palpacelli; Marco Valsecchi; Adriano Tagliabracci; Mauro Pesaresi
Journal:  Int J Legal Med       Date:  2021-06-29       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.